Official Title
Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19
Brief Summary

COVID-19 outbreak is often lethal. Mortality has been associated with several cardio-vascular risk factors such as diabetes, obesity, hypertension and tobacco use. Other clinico-biological features predictive of mortality or transfer to Intensive Care Unit are also needed. Cases of myocarditis have also been reported with COVID-19. Cardio-vascular events have possibly been highly underestimated. The study proposes to systematically collect cardio-vascular data to study the incidence of myocarditis and coronaropathy events during COVID-19 infection.We will also assess predictive factors for transfer in Intensive Care Unit or death.

Recruiting
COVID-19
Myocardial Injury
Myocarditis

Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care
12 derivations electrocardiogram done at baseline and repeated every 3 days
transthoracic echocardiography at baseline
clinical features at baseline: WHO performans status comorbidities and treatments
biological results in routine care, such as baseline full blood count, inflammation markers: C-reactive protein, procalcitonin, interleukin-6 and ferritin, coagulation and troponin and brain natriuretic peptide
COVID-19 patients

Eligibility Criteria

Inclusion Criteria:

- COVID-19 positive patients admitted in a ward identified by positive PCR on nasal swab
samples

Exclusion Criteria:

- Patients who refused the use of their routine care data after information by
investigators.

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years
Countries
France
Contacts

Joe-Elie Salem, MD-PhD
01 42 17 85 31 +33
joe-elie.salem@aphp.fr

Groupe Hospitalier Pitié-Salpêtrière
NCT Number
Keywords
Coronavirus
Heart conditions
Cardio-vascular outcomes
MeSH Terms
Myocarditis